Codes / ICD10CM / M1A.2421

M1A.2421 Drug-induced chronic gout, left hand, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Left Hand, with Tophus (tophi)

Summary

Drug-induced chronic gout, left hand, with tophus (tophi) is a form of arthritis affecting the left hand joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the left hand.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left hand joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense left hand joint pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected left hand joints
  • Formation of tophi (hard, painless lumps) around the left hand joints
  • Stiffness and limited range of motion in the left hand
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging studies. A healthcare provider assesses symptoms, reviews medication history, and may order blood tests to measure uric acid levels. Imaging, such as X-rays or ultrasound, can detect tophi or joint damage. Joint fluid analysis may confirm urate crystal presence.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications like urate-lowering agents (e.g., allopurinol) are used long-term. Anti-inflammatory drugs (NSAIDs, colchicine) address acute flare-ups. Tophi may require surgical removal in severe cases. Lifestyle modifications, such as dietary changes, support management.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and tophi may shrink or resolve. Regular follow-up ensures medication efficacy and monitors for complications. Untreated, the condition may progress to joint deformity or chronic pain. Adherence to therapy and lifestyle adjustments improves outcomes.

Complications

  • Chronic joint damage or deformity in the left hand
  • Persistent pain and reduced mobility
  • Increased risk of kidney stones or renal impairment
  • Tophus-related skin breakdown or infection

Lifestyle & Prevention

  • Avoid medications known to raise uric acid levels when possible.
  • Maintain a balanced diet low in purines (e.g., limit red meat, alcohol).
  • Stay hydrated to support uric acid excretion.
  • Manage weight and exercise regularly to reduce flare risks.

When to Seek Professional Help

Seek care if experiencing severe left hand pain, swelling, or sudden worsening of symptoms. Prompt evaluation is needed for signs of infection, rapid tophus growth, or inability to move the hand. Regular check-ups are recommended for ongoing management.

Tips for Medical Coders

Document the presence of tophi and specify the left hand involvement. Ensure medication history and clinical findings supporting drug-induced gout are clearly recorded. Code M1A.2421 is used when tophus is present in the left hand due to drug-induced chronic gout. Verify documentation aligns with the code’s specificity.

Book a walkthrough

M1A.2421 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.